Results 131 to 140 of about 13,919 (205)

BAP1 Loss in Pleural Mesothelioma Is Associated With Reduced Soluble CCL2 in Patient Effusion, Abrogated CCL2-Mediated Monocyte Recruitment In Vitro. [PDF]

JTO Clin Res Rep
Nash A, Rouse E, Firth T, Dick IM, Fear VS, Forbes CA, Louw A, Lee YCG, Redwood AJ, Robinson BW, Creaney J.   +10 more
europepmc   +1 more source

BAP1 deficiency-induced SKA3 promotes clear cell renal cell carcinoma malignant progression by regulating chromosomal instability. [PDF]

Cell Death Dis
Wang Y, Lai C, Wang L, Deng J, Tian Z, Liang Z, Zhang H.   +6 more
europepmc   +1 more source

Sex-Specific Patterns of Asbestos Exposure and Prognostic Biomarkers in Surgically Treated Pleural Mesothelioma: A Retrospective Cohort Study. [PDF]

Cancers (Basel)
Pinzon N, Gulati S, Re AD, Taioli E, Flores R, Wolf AS, Tuminello S.   +6 more
europepmc   +1 more source

RBM5 Acts as a Tumor Suppressor in Breast Cancer Through Binding to G-quadruplexes in the BAP1 Gene Promoter to Activate Its Expression. [PDF]

Molecules
Li Y, Wang W, Li G, Wang H, Cong S, Yang C, Ma B, Li D, Sui G.   +8 more
europepmc   +1 more source

Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). [PDF]

Mol Med Rep
Cui H, Song J, Yang P, Zhang Z, Liu Y, Zhang G, Tian A, Che J, Liu Y, Sun H, Xu Y.   +10 more
europepmc   +1 more source

BAP1 Gene Mutation Negative [PDF]

, 2020
openaire   +1 more source

Occurrence of BAP1 mutations in families [PDF]

Acta Ophthalmologica, 2018
openaire   +1 more source

Molecular Diagnosis of Melanocytic Neoplasia: Updates and Challenges. [PDF]

Cancers (Basel)
Plotzke JM, Wang G, Bresler SC, Harms PW.   +3 more
europepmc   +1 more source

MTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches. [PDF]

Cancers (Basel)
Cedres S, Masfarre L, Priano I, Valdivia A, Rocha P, Iranzo P, Pardo N, Martinez-Marti A, Arbusà A, Cane L, Soleda M, Sinigaglia B, Polo-Alonso S, Romero-Sola G, Caro-Consuegra R, Ortega A, Felip E.   +16 more
europepmc   +1 more source

BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia. [PDF]

Cancer Immunol Immunother
Badami C, Islamagic E, Blomén L, Svensson F, Kathirkamanathan T, Hellstrand K, Bernson E, Thorén FB.   +7 more
europepmc   +1 more source